u/CommitteeLocal9703 · 384d agono track record yet
$PCSA: Catalyst Watch: Possible Licensing News by Tomorrow + Earnings on Oct 29
Processa Pharmaceuticals' 120-day licensing agreement window with Intact Therapeutics ends October 15, and a signed deal would bring $2.5M upfront plus up to $452.5M in potential milestones and royalties. The low-float micro-cap setup and upcoming earnings on October 29 create near-term catalysts that could drive a significant re-rating if the deal closes and validates the strategy of monetizing non-core assets.
At post $9.90live price unavailable
1d+3.5%
3d-22.7%
1w-24.2%
1m-26.3%
3m-68.3%
6m-72.0%
1y-83.7%